Urs Patrick Fisch, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Status Epilepticus | 6 | 2024 | 459 | 2.820 |
Why?
|
| Anesthetics | 2 | 2023 | 524 | 1.150 |
Why?
|
| Endarterectomy, Carotid | 2 | 2021 | 563 | 1.010 |
Why?
|
| Carotid Stenosis | 2 | 2021 | 868 | 0.880 |
Why?
|
| Mastoiditis | 1 | 2024 | 37 | 0.880 |
Why?
|
| Ventilator Weaning | 1 | 2024 | 170 | 0.830 |
Why?
|
| Baclofen | 1 | 2023 | 121 | 0.820 |
Why?
|
| Hypoxia, Brain | 1 | 2023 | 139 | 0.790 |
Why?
|
| Anticonvulsants | 5 | 2024 | 1919 | 0.780 |
Why?
|
| Meningitis, Bacterial | 1 | 2024 | 222 | 0.760 |
Why?
|
| Brain Death | 1 | 2023 | 360 | 0.680 |
Why?
|
| Medication Therapy Management | 1 | 2021 | 131 | 0.670 |
Why?
|
| Automobile Driving | 1 | 2024 | 441 | 0.640 |
Why?
|
| Lateral Ventricles | 1 | 2020 | 142 | 0.620 |
Why?
|
| Blood Chemical Analysis | 1 | 2020 | 434 | 0.620 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2020 | 361 | 0.620 |
Why?
|
| Valproic Acid | 1 | 2020 | 444 | 0.580 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 3 | 2011 | 20 | 0.540 |
Why?
|
| Electroencephalography | 4 | 2024 | 6274 | 0.520 |
Why?
|
| Mannose-Binding Lectin | 3 | 2011 | 146 | 0.480 |
Why?
|
| Neurogenesis | 2 | 2020 | 863 | 0.450 |
Why?
|
| Epilepsy | 2 | 2024 | 3317 | 0.390 |
Why?
|
| Critical Care | 1 | 2024 | 2712 | 0.370 |
Why?
|
| Graft vs Host Disease | 1 | 2024 | 3078 | 0.360 |
Why?
|
| Microglia | 1 | 2020 | 1370 | 0.360 |
Why?
|
| Heart | 1 | 2023 | 4418 | 0.340 |
Why?
|
| Switzerland | 3 | 2024 | 322 | 0.330 |
Why?
|
| Coma | 2 | 2023 | 485 | 0.330 |
Why?
|
| Stroke | 6 | 2023 | 9750 | 0.320 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 3641 | 0.290 |
Why?
|
| Neurofilament Proteins | 2 | 2019 | 336 | 0.270 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2024 | 5753 | 0.250 |
Why?
|
| Guanosine Triphosphate | 1 | 2024 | 313 | 0.210 |
Why?
|
| Glypicans | 1 | 2023 | 33 | 0.210 |
Why?
|
| Midazolam | 1 | 2024 | 267 | 0.200 |
Why?
|
| Administration, Intranasal | 1 | 2024 | 482 | 0.200 |
Why?
|
| Seizures | 3 | 2024 | 2999 | 0.190 |
Why?
|
| Brain | 3 | 2023 | 27177 | 0.170 |
Why?
|
| Atrial Fibrillation | 3 | 2023 | 5188 | 0.160 |
Why?
|
| Stents | 2 | 2021 | 3236 | 0.160 |
Why?
|
| Pregnancy, High-Risk | 1 | 2019 | 121 | 0.160 |
Why?
|
| Asphyxia Neonatorum | 1 | 2020 | 112 | 0.160 |
Why?
|
| Humans | 28 | 2024 | 766011 | 0.150 |
Why?
|
| Cerebral Revascularization | 1 | 2021 | 260 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2019 | 561 | 0.150 |
Why?
|
| Silver | 1 | 2018 | 120 | 0.150 |
Why?
|
| Intermediate Filaments | 1 | 2018 | 171 | 0.140 |
Why?
|
| Chlorhexidine | 1 | 2018 | 159 | 0.140 |
Why?
|
| Serum Albumin | 1 | 2020 | 676 | 0.140 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2018 | 109 | 0.140 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2018 | 187 | 0.140 |
Why?
|
| Animals, Newborn | 2 | 2020 | 2670 | 0.140 |
Why?
|
| Bandages | 1 | 2018 | 269 | 0.140 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2018 | 245 | 0.130 |
Why?
|
| Cerebral Ventricles | 1 | 2018 | 550 | 0.130 |
Why?
|
| Waiting Lists | 1 | 2021 | 777 | 0.130 |
Why?
|
| Intracranial Hypertension | 1 | 2018 | 190 | 0.130 |
Why?
|
| Parturition | 1 | 2019 | 453 | 0.120 |
Why?
|
| Catheter-Related Infections | 1 | 2018 | 279 | 0.120 |
Why?
|
| Secondary Prevention | 1 | 2021 | 1471 | 0.120 |
Why?
|
| Language | 1 | 2024 | 1550 | 0.110 |
Why?
|
| Academic Medical Centers | 1 | 2023 | 2780 | 0.110 |
Why?
|
| Vascular Surgical Procedures | 1 | 2021 | 1516 | 0.100 |
Why?
|
| Neural Stem Cells | 2 | 2017 | 897 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 1065 | 0.100 |
Why?
|
| Pre-Eclampsia | 2 | 2019 | 1261 | 0.100 |
Why?
|
| Cohort Studies | 4 | 2023 | 41652 | 0.100 |
Why?
|
| Neuropeptides | 1 | 2017 | 951 | 0.090 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 1 | 2011 | 28 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2020 | 8103 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 750 | 0.090 |
Why?
|
| Drug Monitoring | 1 | 2017 | 961 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2022 | 24299 | 0.090 |
Why?
|
| Brain Ischemia | 1 | 2023 | 3001 | 0.080 |
Why?
|
| Medical Audit | 1 | 2011 | 454 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2023 | 5343 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 3804 | 0.080 |
Why?
|
| Adult | 8 | 2024 | 223109 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2016 | 1063 | 0.080 |
Why?
|
| Sleep | 1 | 2024 | 4823 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2023 | 3421 | 0.070 |
Why?
|
| Female | 14 | 2024 | 396159 | 0.070 |
Why?
|
| Rats | 2 | 2020 | 23702 | 0.060 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2008 | 327 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2022 | 54818 | 0.060 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 2082 | 0.060 |
Why?
|
| Aged | 6 | 2023 | 171233 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2015 | 2061 | 0.050 |
Why?
|
| Algorithms | 1 | 2024 | 14061 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2023 | 81522 | 0.050 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2023 | 127 | 0.050 |
Why?
|
| Male | 10 | 2024 | 363808 | 0.050 |
Why?
|
| Middle Aged | 6 | 2024 | 223058 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2018 | 8537 | 0.050 |
Why?
|
| Neoplasms | 1 | 2011 | 22350 | 0.050 |
Why?
|
| Phenotype | 1 | 2020 | 16707 | 0.050 |
Why?
|
| Fetal Blood | 1 | 2008 | 1369 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2018 | 7845 | 0.050 |
Why?
|
| Interleukin-13 | 1 | 2023 | 388 | 0.040 |
Why?
|
| Cognition | 1 | 2018 | 7048 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2023 | 700 | 0.040 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2019 | 113 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2023 | 1162 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2011 | 3078 | 0.040 |
Why?
|
| Vitamin K | 1 | 2021 | 312 | 0.040 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2019 | 348 | 0.040 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2018 | 83 | 0.040 |
Why?
|
| Glycopeptides | 1 | 2019 | 224 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 2021 | 286 | 0.040 |
Why?
|
| Cerebral Hemorrhage | 2 | 2022 | 2649 | 0.040 |
Why?
|
| Atrophy | 1 | 2022 | 1629 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2023 | 1183 | 0.040 |
Why?
|
| Hematologic Neoplasms | 1 | 2009 | 1927 | 0.040 |
Why?
|
| Intracranial Thrombosis | 1 | 2018 | 109 | 0.030 |
Why?
|
| Anticoagulants | 2 | 2023 | 4863 | 0.030 |
Why?
|
| Chromogenic Compounds | 1 | 2017 | 29 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2018 | 438 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2023 | 1896 | 0.030 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2015 | 16 | 0.030 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2015 | 59 | 0.030 |
Why?
|
| Progesterone | 1 | 2019 | 752 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2018 | 1589 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2015 | 574 | 0.030 |
Why?
|
| Intracranial Pressure | 1 | 2015 | 323 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3229 | 0.030 |
Why?
|
| Animals | 3 | 2020 | 168721 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2015 | 591 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2019 | 1200 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2019 | 946 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 2019 | 840 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2018 | 767 | 0.020 |
Why?
|
| Cell Death | 1 | 2017 | 1678 | 0.020 |
Why?
|
| Risk Factors | 4 | 2023 | 74870 | 0.020 |
Why?
|
| Craniotomy | 1 | 2015 | 731 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2023 | 42481 | 0.020 |
Why?
|
| Recurrence | 1 | 2021 | 8505 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 1327 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 1170 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 1994 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 6307 | 0.020 |
Why?
|
| Pregnancy | 2 | 2019 | 30253 | 0.020 |
Why?
|
| Complement Activation | 1 | 2008 | 430 | 0.020 |
Why?
|
| Young Adult | 3 | 2018 | 59870 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 2513 | 0.020 |
Why?
|
| Child | 2 | 2011 | 80510 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5304 | 0.020 |
Why?
|
| Infant | 2 | 2023 | 36377 | 0.020 |
Why?
|
| Time Factors | 2 | 2017 | 40117 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2017 | 1938 | 0.020 |
Why?
|
| Skin | 1 | 2018 | 4479 | 0.010 |
Why?
|
| Prognosis | 2 | 2018 | 29915 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21507 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13615 | 0.010 |
Why?
|
| Adolescent | 2 | 2018 | 88804 | 0.010 |
Why?
|
| Gestational Age | 1 | 2008 | 3615 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 4136 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 6838 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20125 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18289 | 0.010 |
Why?
|
| Radiography | 1 | 2008 | 6938 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39226 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 59526 | 0.010 |
Why?
|
| Survival Rate | 1 | 2009 | 12821 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 65236 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2015 | 15803 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20676 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 22230 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 26341 | 0.000 |
Why?
|